new_0222_0712|EVAX|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0712|EVAX|Long Name|1|1|Evaxion Biotech AS Total Current Assets (Quarterly) (USD)|Evaxion Biotech AS Cash and Short Term Investments (Quarterly) (USD)|Evaxion Biotech AS Inventories (Quarterly) (USD)|Evaxion Biotech AS Net PP&E (Quarterly) (USD)|Evaxion Biotech AS Goodwill and Intangibles (Quarterly) (USD)|Evaxion Biotech AS Total Liabilities (Quarterly) (USD)|Evaxion Biotech AS Total Current Liabilities (Quarterly) (USD)|Evaxion Biotech AS Total Long Term Liabilities (Quarterly) (USD)|Evaxion Biotech AS Total Deposits (Quarterly) (USD)|Evaxion Biotech AS Book Value (Quarterly) (USD)|Evaxion Biotech AS Retained Earnings (Quarterly) (USD)|Evaxion Biotech AS Treasury Stock (Quarterly) (USD)|Evaxion Biotech AS EV to Revenues|Evaxion Biotech AS EV to Earnings|Evaxion Biotech AS EV to Free Cash Flow|Evaxion Biotech AS EV to Assets (Quarterly)|Evaxion Biotech AS PS Ratio|Evaxion Biotech AS PE Ratio|Evaxion Biotech AS Price to Book Value|Evaxion Biotech AS PEG Ratio|Evaxion Biotech AS Debt to Equity Ratio|Evaxion Biotech AS Dividend Yield|Evaxion Biotech AS Shareholder Yield (TTM)|Evaxion Biotech AS Percent of Shares Outstanding Short|Evaxion Biotech AS Total Receivables (Quarterly) (USD)|Evaxion Biotech AS Total Payables (Quarterly) (USD)|Evaxion Biotech AS Total Capital Stock (Quarterly) (USD)|Evaxion Biotech AS Return on Invested Capital|Evaxion Biotech AS Quality Ratio Score|Evaxion Biotech AS Momentum Score|Evaxion Biotech AS Beta (1Y)|Evaxion Biotech AS Sustainable Growth Rate (TTM)|Evaxion Biotech AS Institutional Investor Ownership Percentage|Evaxion Biotech AS Average Diluted Shares Outstanding (Quarterly)|Evaxion Biotech AS Total Employees (Annual)|Evaxion Biotech AS EPS Diluted (Quarterly) (USD)|Evaxion Biotech AS SG&A Expense (Quarterly) (USD)|Evaxion Biotech AS Shares Outstanding|Evaxion Biotech AS Repurchase of Capital Stock (Quarterly) (USD)|Evaxion Biotech AS Ordinary Shares Number (Quarterly)|Evaxion Biotech AS Payout Ratio|Evaxion Biotech AS Quick Ratio (Quarterly)|Evaxion Biotech AS Normalized Diluted EPS (Quarterly) (USD)|Evaxion Biotech AS Stock Buybacks (Quarterly) (USD)|Evaxion Biotech AS Effective Tax Rate (TTM)|Evaxion Biotech AS Return on Equity|Evaxion Biotech AS Net Income (TTM) (USD)|Evaxion Biotech AS Revenue (TTM) (USD)|Evaxion Biotech AS Dividend Per Share (Quarterly) (USD)|Evaxion Biotech AS Revenue (Quarterly) (USD)|Evaxion Biotech AS Gross Profit (Quarterly) (USD)|Evaxion Biotech AS Pre-Tax Income (Quarterly) (USD)|Evaxion Biotech AS Net Income (Quarterly) (USD)|Evaxion Biotech AS Net Interest Income (Quarterly) (USD)|Evaxion Biotech AS Price (USD)|Evaxion Biotech AS Total Return Price (USD)|Evaxion Biotech AS Enterprise Value (USD)|Evaxion Biotech AS 30-Day Average Daily Volume|Evaxion Biotech AS 1 Year Price Returns (Daily)|Evaxion Biotech AS Short Interest|Evaxion Biotech AS PE Ratio (Forward)|Evaxion Biotech AS PE Ratio (Forward 1y)|Evaxion Biotech AS PS Ratio (Forward)|Evaxion Biotech AS PS Ratio (Forward 1y)|Evaxion Biotech AS Quarterly EPS Estimates (USD)|Evaxion Biotech AS Quarterly Revenue Estimates (USD)|Evaxion Biotech AS Quarterly EPS Surprise|Evaxion Biotech AS Quarterly Revenue Surprise|Evaxion Biotech AS Quarterly Actual EPS (USD)|Evaxion Biotech AS Quarterly Actual Revenue (USD)|Evaxion Biotech AS Revenue Estimates for Current Fiscal Year (USD)|Evaxion Biotech AS Revenue Estimates for Next Fiscal Year (USD)|Evaxion Biotech AS Price Target (USD)|Evaxion Biotech AS Consensus Recommendation|Evaxion Biotech AS Price Target Num Estimates|Evaxion Biotech AS EPS Estimates for Current Fiscal Year (USD)|Evaxion Biotech AS EPS Estimates for Next Fiscal Year (USD)|Evaxion Biotech AS Research and Development Expense (Quarterly) (USD)|Evaxion Biotech AS Reconciled Depreciation (Quarterly) (USD)|Evaxion Biotech AS Non-Operating Interest Expense (Quarterly) (USD)|Evaxion Biotech AS Land and Improvements (Quarterly) (USD)|Evaxion Biotech AS Buildings and Improvements (Quarterly) (USD)|Evaxion Biotech AS Other Properties (Quarterly) (USD)|Evaxion Biotech AS Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0712|EVAX|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0712|EVAX||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0712|EVAX||5|5|127.8|127.8|0|127.8|127.8|127.8|127.8|127.8|0|127.8|127.8|0|0|0|1.4427480916|0|0|0|1.4427480916|0|0|1.4427480916|0|15.347826087|127.8|127.8|127.8|0|0|0|0|0|30.6|91.2857142857|0|91.2857142857|91.2857142857|39.125|0|127.8|0|0|91.2857142857|91.3333333333|91.25|0|91.25|0|0|0|0|91.2857142857|91.2857142857|91.2857142857|1.4427480916|1.4427480916|1.4427480916|1.44206008584|1.22222222222|15.347826087|0|0|0|0|91.25|91.25|91.5|0|91.5|91|32.5833333333|31.625|28.1|22|28.1|30.6666666667|28.1111111111|91.2857142857|0|91.2857142857|0|0|127.8|0
new_0222_0712|EVAX||6|6|5|5|0|5|5|5|5|5|0|5|5|0|0|0|262|0|0|0|262|0|0|262|0|23|5|5|5|0|0|0|0|0|10|7|0|7|7|8|0|5|0|0|7|6|4|0|4|0|0|0|0|7|7|7|262|262|262|233|9|23|0|0|0|0|4|8|2|0|2|3|12|8|10|15|10|12|9|7|0|7|0|0|5|0
new_0222_0712|EVAX||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0712|EVAX|201912|201912|201912|10.958|9.559||0.126|0|1.722|1.722|0||9.362|-15.812||||||||||||||0.931|1.411|2.481|||||||19.1987||-0.1833|0.761|||16.1987|||-0.1833|||||||||-3.778|-3.519|-0.111||||||||||||||||||||||||2.946|0.03|0.036|||0.272|
new_0222_0712|EVAX|202003|202003|202003||||||||||||||||||||||||||||||||||19.1987||-0.1614|0.781||||||-0.1614|0||||||||-3.279|-3.099|0.012||||||||||||||||||||||||2.51||0.004||||
new_0222_0712|EVAX|202006|202006|202006||||||||||||||||||||||||||||||||||19.1987||-0.1896|1.372||||||-0.1896|0||||||||-3.936|-3.64|0.006||||||||||||||||||||||||2.57||0||||
new_0222_0712|EVAX|202009|202009|202009|10.413|7.876||0.213|0.037|3.372|3.372|0||7.903|-23.767||||||||||||||0.475|3.334|2.603|||||||16.1987||-0.2476|1.719|||16.1987|||-0.2476|-6.626|8.4269||-14.268|||||-4.588|-4.01|0.097||||||||||||||||||||||||2.966||0.003|||0.166|
new_0222_0712|EVAX|202012|202012|202012|10.95|5.834||0.457|0.1|4.927|4.927|0||7.038|-27.279||||||||||||||1.794|3.853|2.648|||||||16.1987|35|-0.2635|1.782|16.1987||16.1987|||-0.2635|-2.394|9.3937||-15.018|||||-4.772|-4.269|-0.144|||||||||||-0.25|0||||0|0|||||-0.95||2.856||0.022|||0.52|
new_0222_0712|EVAX|202101|202012|202012||||||||||||||||||||||||||||||||||||||18.9487||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0712|EVAX|202102|202012|202012|||||||||||||||-9.9893||||19.0405|||0||0.0285||||||||||||||19.1987|||||||||||||||||6.98|6.98|128.1729|||5473||||||||||||||||||||||||
new_0222_0712|EVAX|202103|202103|202103|32.487|26.955||1.793|0.096|7.121|6.016|1.105||27.799|-31.078||||-6.0813||||4.0747|||0||0.017|1.612|5.961|3.132||||||4.6044|17.8653||-0.23|1.282|19.1987||19.1987|||-0.23|-27.9|10.0247||-16.012|||||-4.5|-4.093|0.675|5.9|5.9|86.3173|86232.6667||3260|||||-0.33|0|30.303||-0.23|0|0|0|20.5|1|2|-1.21|-1.76|3.893||0.297|||1.6|
new_0222_0712|EVAX|202104|202103|202103|||||||||||||||-7.7449||||4.9242|||0||0.0858|||||||||4.6044||||||||||||||||||||||7.13|7.13|109.9317|95342.0333||16476|||||||||||0|0|20.5|1|2|-1.32|-1.88|||||||
new_0222_0712|EVAX|202105|202103|202103|||||||||||||||-7.2174||||4.6548|||0||0.0127|||||||||4.6044|||||19.1987|||||||||||||||||6.74|6.74|102.4442|32844.6667||2447|||||||||||0|0|20.5|1|2|-1.2|-1.8|||||||
new_0222_0712|EVAX|202106|202106|202106|23.425|18.799||2.276|0.097|5.828|4.801|1.027||21.829|-37.471||||-6.541||||6.8074|||0||0.146|1.797|4.665|3.132||||||2.2895|19.1987||-0.36|1.915|19.1987||19.1987|||-0.36|0|10.104||-19.191|||||-7.488|-6.819|-0.462|7.74|7.74|129.7989|123011.5||28034|||||-0.295|0|-22.0339||-0.36|0|||20.5|1|2|||5.111||0.495|||2.076|
new_0222_0712|EVAX|202107|202106|202106|||||||||||||||-4.2771||||4.7493|||0||0.1779|||||||||2.2895||||||||||||||||||||||5.4|5.4|84.874|57292.4||34163|||||||||||0|0|20.6667|1|3|-1.205|-1.8|||||||
new_0222_0712|EVAX|202108|202106|202106|||||||||||||||-5.3703||||5.7432|||0||0.1787|||||||||2.2895||||||||||||||||||||||6.53|6.53|106.5685|23827.6||34307|||||||||||0|0|19|1|3|-1.31|-1.83|||||||
new_0222_0712|EVAX|202109|202109|202109|16.317|11.944||5.35|0.095|7.466|3.922|3.544||16.65|-42.14||||-7.357||||11.1156|||0||0.203|1.719|3.444|3.132||||||1.7825|19.4444||-0.27|1.495|19.1987||19.1987|||-0.27|-0.001|8.9325||-20.431|||||-5.675|-5.25|0.237|9.64|9.64|174.3905|163044.1667||38965|||||-0.345|0|21.7391||-0.27|0||||||||4.417||0.051|||5.156|
new_0222_0712|EVAX|202110|202109|202109|||||||||||||||-5.7128||||8.7749|||0||0.1527|||||||||1.7825||||||||||||||||||||||7.61|7.61|135.4171|34642.1333||29315|||||||||||0|0|19|1|3|-1.31|-1.83|||||||
new_0222_0712|EVAX|202111|202109|202109|||||||||||||||-4.0986||||6.4768|||0||0.0969|||||||||1.4788|||||23.1415|||||||||||||||||4.66|4.66|97.1544|1765026.2||22423|||||||||||0|0|18|1|3|-1.18|-1.56|||||||
new_0222_0712|EVAX|202112|202112|202112|||||||||||||||-3.8643||||6.1433|||0||0.1671|||||||||1.4788||||||||||||||||||||||4.42|4.42|91.6004|218249||38676|||||-0.3|0|||||0||16.25|1|4|-1.17||||||||
new_0222_0712|EVAX|202201|202112|202112|||||||||||||||-2.6147||||4.3642|||0||0.2086|||||||||1.4712||||||||||||||||||||||3.14|3.14|61.9793|140014.8667||48267|||||||||||0|||1||-1.505||||||||
new_0222_0712|EVAX|202202|202112|202112|||||||||||||||-2.4878||||4.1835|||0|||||||||||||||||||||||||||||||||3.01|3.01|58.9709|91620.0667|-65.3625|||||||||||||||||||||||||
new_0222_0712|EVAX|202203|202203|202203||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||
new_0222_0712|EVAX|202206|202206|202206||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||
new_0222_0712|EVAX|202209|202209|202209||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||
new_0222_0712|EVAX|202212|202212|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||